A Review of Monocytes and Monocyte-Derived Cells in Hypertrophic Scarring Post Burn

Journal of Burn Care and Research

Volumn 37, Issue 5, 2016, Pages 265-272

  Suda, Sasithorn ^a,b,c   Williams, Helen ^b,c   Medbury, Heather J ^b,c   Holland, Andrew J A ^a,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL SURFACE MARKER; COLLAGEN; CYTOKINE; SCLEROPROTEIN;

BURN; CELL DIFFERENTIATION; CLINICAL OUTCOME; HUMAN; HYPERTROPHIC SCAR; IMMUNE SYSTEM; IMMUNITY; MACROPHAGE; MONOCYTE; NONHUMAN; REVIEW; SCAR FORMATION; TISSUE REPAIR; UPREGULATION; WOUND HEALING; CYTOLOGY; FIBROSIS; METABOLISM; PATHOLOGY;

BURNS; CICATRIX, HYPERTROPHIC; COLLAGEN; FIBROSIS; HUMANS; MACROPHAGES; MONOCYTES; WOUND HEALING;

EID: 84986320247     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0000000000000312     Document Type: Review

References (98)

1. Turner C, Spinks A, McClure R, Nixon J. Community-based interventions for the prevention of burns and scalds in children. Cochrane Database Syst Rev 2004:CD004335.
2. Dissanaike S, Rahimi M. Epidemiology of burn injuries: highlighting cultural and socio-demographic aspects. Int Rev Psychiatry 2009;21:505-11.
3. Rayner R, Prentice J. Paediatric burns: a brief global review. Wound Practice Res. 2011;9:39-46.
4. van der Veer WM, Bloemen MC, Ulrich MM, et al. Potential cellular and molecular causes of hypertrophic scar formation. Burns 2009;35:15-29.
5. Shankar R, Melstrom KA Jr, Gamelli RL. Inflammation and sepsis: past, present, and the future. J Burn Care Res 2007;28:566-71.
6. Sakallioglu AE, Basaran O, Karakayali H, et al. Interactions of systemic immune response and local wound healing in different burn depths: an experimental study on rats. J Burn Care Res 2006;27:357-66.
7. Molloy RG, O'Riordain M, Holzheimer R, et al. Mechanism of increased tumor necrosis factor production after thermal injury. Altered sensitivity to PGE2 and immunomodulation with indomethacin. J Immunol 1993;151:2142-9.
8. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001;166:7556-62.
9. Reilkoff RA, Bucala R, Herzog EL. Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol 2011;11:427-35.
10. Pilling D, Fan T, Huang D, Kaul B, Gomer RH. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 2009;4:e7475.
11. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958-69.
12. Shen H, de Almeida PE, Kang KH, Yao P, Chan CW. Burn injury triggered dysfunction in dendritic cell response to TLR9 activation and resulted in skewed T cell functions. PLoS One 2012;7:e50238.
13. Loose LD, Megirian R, Turinsky J. Biochemical and functional alterations in macrophages after thermal injury. Infect Immun 1984;44:554-8.
14. Engrav LH, Garner WL, Tredget EE. Hypertrophic scar, wound contraction and hyper-hypopigmentation. J Burn Care Res 2007;28:593-7.
15. Bayat A, McGrouther DA, Ferguson MW. Skin scarring. BMJ 2003;326:88-92.
16. Hassan S, Reynolds G, Clarkson J, Brooks P. Challenging the dogma: relationship between time to healing and formation of hypertrophic scars after burn injuries. J Burn Care Res 2014;35:e118-24.
17. Farquhar K. Silicone gel and hypertrophic scar formation: a literature review. Can J Occup Ther 1992;59:78-86.
18. Gauglitz GG. Management of keloids and hypertrophic scars: current and emerging options. Clin Cosmet Investig Dermatol 2013;6:103-14.
19. Gross J. Collagen. Scientific American 1961;204(5): 121-130.
20. Oliveira GV, Hawkins HK, Chinkes D, et al. Hypertrophic versus non hypertrophic scars compared by immunohistochemistry and laser confocal microscopy: type I and III collagens. Int Wound J 2009;6:445-52.
21. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35.
22. Brodsky B, Thiagarajan G, Madhan B, Kar K. Triple-helical peptides: an approach to collagen conformation, stability, and self-association. Biopolymers 2008;89:345-53.
23. Ruszczak Z. Effect of collagen matrices on dermal wound healing. Adv Drug Deliv Rev 2003;55:1595-611.
24. Reinke JM, Sorg H. Wound repair and regeneration. Eur Surg Res 2012;49:35-43.
25. Verhaegen PD, van Zuijlen PP, Pennings NM, et al. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis. Wound Repair Regen 2009;17:649-56.
26. Riekki R, Parikka M, Jukkola A, Salo T, Risteli J, Oikarinen A. Increased expression of collagen types I and III in human skin as a consequence of radiotherapy. Arch Dermatol Res 2002;294:178-84.
27. Hsu A, Mustoe T. The principles of wound healing. Fundamental principles of plastic surgery. Maryland Heights, Maryland: Mosby; 2010.
28. Yeoh C, Nixon JW, Dickson W, Kemp A, Sibert JR. Patterns of scald injuries. Arch Dis Child 1994;71:156-8.
29. Yeo GC, Baldock C, Wise SG, Weiss AS. A negatively charged residue stabilizes the tropoelastin N-terminal region for elastic fiber assembly. J Biol Chem 2014;289:34815-26.
30. Amadeu TP, Braune AS, Porto LC, Desmoulière A, Costa AM. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids. Wound Repair Regen 2004;12:169-74.
31. Bhangoo KS, Quinlivan JK, Connelly JR. Elastin fibers in scar tissue. Plast Reconstr Surg 1976;57:308-13.
32. Sidgwick GP, Bayat A. Extracellular matrix molecules implicated in hypertrophic and keloid scarring. J Eur Acad Dermatol Venereol 2012;26:141-52.
33. Deitch EA, Wheelahan TM, Rose MP, Clothier J, Cotter J. Hypertrophic burn scars: analysis of variables. J Trauma 1983;23:895-8.
34. Juckett G, Hartman-Adams H. Management of keloids and hypertrophic scars. Am Fam Physician 2009;80:253-60.
35. Aarabi S, Longaker MT, Gurtner GC. Hypertrophic scar formation following burns and trauma: new approaches to treatment. PLoS Med 2007;4:e234.
36. Amadeu TP, Braune AS, Porto LC, Desmoulière A, Costa AM. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids. Wound Repair Regen 2004;12:169-74.
37. Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res 2010;89:219-29.
38. Bloemen MC, van der Veer WM, Ulrich MM, van Zuijlen PP, Niessen FB, Middelkoop E. Prevention and curative management of hypertrophic scar formation. Burns 2009;35:463-75.
39. Lai JJ, Lai KP, Chuang KH, et al. Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression. J Clin Invest 2009;119:3739-51.
40. Flanagan M. The responsibility is yours. J Wound Care 2000;9:357.
41. Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 2010;121:2437-45.
42. Mirza R, DiPietro LA, Koh TJ. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 2009;175:2454-62.
43. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011;11:723-37.
44. Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 2010;30:245-57.
45. Liu H, Ding J, Ma Z, et al. A novel subpopulation of peripheral blood mononuclear cells presents in major burn patients. Burns 2015;41:998-1007.
46. Amini-Nik S, Cambridge E, Yu W, et al. β-Catenin-regulated myeloid cell adhesion and migration determine wound healing. J Clin Invest 2014;124:2599-610.
47. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992;189:824-31.
48. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res 2009;153:347-58.
49. Wang JF, Jiao H, Stewart TL, Shankowsky HA, Scott PG, Tredget EE. Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen 2007;15:113-21.
50. Mori L, Bellini A, Stacey MA, Schmidt M, Mattoli S. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 2005;304:81-90.
51. Williamson D, Harding K. Wound healing. Medicine 2004;32:4-7.
52. Nedelec B, Shankowsky H, Scott PG, Ghahary A, Tredget EE. Myofibroblasts and apoptosis in human hypertrophic scars: the effect of interferon-alpha2b. Surgery 2001;130:798-808.
53. Metz CN. Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 2003;60:1342-50.
54. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-46.
55. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994;1:71-81.
56. Holland AJ, Tarran SL, Medbury HJ, Guiffre AK. Are fibrocytes present in pediatric burn wounds? J Burn Care Res 2008;29:619-26.
57. Yang L, Scott PG, Dodd C, et al. Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen 2005;13:398-404.
58. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994;1:71-81.
59. Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004;36:598-606.
60. Grieb G, Steffens G, Pallua N, Bernhagen J, Bucala R. Circulating fibrocytes-biology and mechanisms in wound healing and scar formation. Int Rev Cell Mol Biol 2011;291:1-19.
61. Chesney J, Metz C, Stavitsky A, et al. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol. 2014;160:419-25.
62. Grieb G, Bucala R. Fibrocytes in fibrotic diseases and wound healing. Adv Wound Care (New Rochelle) 2012;1:36-40.
63. Stewart TL, Ball B, Schembri PJ, et al; Wound Healing Research Group. The use of laser Doppler imaging as a predictor of burn depth and hypertrophic scar postburn injury. J Burn Care Res 2012;33:764-71.
64. Yang L, Scott PG, Giuffre J, Shankowsky HA, Ghahary A, Tredget EE. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 2002;82:1183-92.
65. Yang H, Zhang R, Mu H, Li M, Yao Q, Chen C. Adiponectin promotes endothelial cell differentiation from human peripheral CD14+ monocytes in vitro. J Cell Mol Med 2006;10:459-69.
66. Wang J, Jiao H, Stewart TL, et al. Accelerated wound healing in leukocyte-specific, protein 1-deficient mouse is associated with increased infiltration of leukocytes and fibrocytes. J Leukoc Biol 2007;82:1554-63.
67. Kao HK, Chen B, Murphy GF, Li Q, Orgill DP, Guo L. Peripheral blood fibrocytes: enhancement of wound healing by cell proliferation, re-epithelialization, contraction, and angiogenesis. Ann Surg 2011;254:1066-74.
68. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5:953-64.
69. Porcheray F, Viaud S, Rimaniol AC, et al. Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 2005;142:481-9.
70. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009;27:451-83.
71. Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 2008;57:3239-46.
72. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010;32:593-604.
73. Geissmann F, Auffray C, Palframan R, et al. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol 2008;86:398-408.
74. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117:175-84.
75. Beyer M, Mallmann MR, Xue J, et al. High-resolution transcriptome of human macrophages. PLoS One 2012;7:e45466.
76. Sironi M, Martinez FO, D'Ambrosio D, et al. Differential regulation of chemokine production by Fcgamma receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2). J Leukoc Biol 2006;80:342-9.
77. Edwards JP, Zhang X, Frauwirth KA, Mosser DM. Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 2006;80:1298-307.
78. Hao NB, Lü MH, Fan YH, Cao YL, Zhang ZR, Yang SM. Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012;2012:948098.
79. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008;13:453-61.
80. Delavary M, van der Veer B, van Egmond WM, et al. Macrophages in skin injury and repair. Immunobiology 2011;216:753-62.
81. Kim JS, Romero R, Tarca AL, et al. Gene expression profiling demonstrates a novel role for foetal fibrocytes and the umbilical vessels in human fetoplacental development. J Cell Mol Med 2008;12:1317-30.
82. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008;13:453-61.
83. Niedermeier M, Reich B, Rodriguez Gomez M, et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci U S A 2009;106:17892-7.
84. Keeley EC, Mehrad B, Strieter RM. Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol 2010;42:535-42.
85. Herzog EL, Bucala R. Fibrocytes in health and disease. Exp Hematol 2010;38:548-56.
86. Osterholzer JJ, Chen GH, Olszewski MA, Curtis JL, Huffnagle GB, Toews GB. Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes. J Immunol 2009;183:8044-53.
87. Medbury HJ, Tarran SL, Guiffre AK, et al. Monocytes contribute to the atherosclerotic cap by transformation into fibrocytes. Int Angiol 2008;27:114-23.
88. Yona S, Jung S. Monocytes: subsets, origins, fates and functions. Curr Opin Hematol 2010;17:53-9.
89. Takahashi K. Development and differentiation of macrophages and related cells: historical review and current concepts. J Clin Exp Hematop. 2000;41:1-31.
90. Balboa L, Romero MM, Laborde E, et al. Impaired dendritic cell differentiation of CD16-positive monocytes in tuberculosis: role of p38 MAPK. Eur J Immunol 2013;43:335-47.
91. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007;81:584-92.
92. Strauss-Ayali D, Conrad SM, Mosser DM. Monocyte subpopulations and their differentiation patterns during infection. J Leukoc Biol 2007;82:244-52.
93. Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 2010;7:77-86.
94. Ziegler-Heitbrock L, Hofer TP. Toward a refined definition of monocyte subsets. Front Immunol 2013;4:23.
95. Wang G, Xia Z. Monocyte subsets and their differentiation tendency after burn injury. Front Med 2013;7:397-400.
96. Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E. Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol 2013;62:1541-51.
97. Charo IF. Macrophage polarization and insulin resistance: PPARgamma in control. Cell Metab 2007;6:96-8.
98. Kobayashi M, Jeschke MG, Shigematsu K, et al. M2b monocytes predominated in peripheral blood of severely burned patients. J Immunol 2010;185:7174-9.